BNT-153

N/A

Report date: 2024/04/24 14:34:01

Base Information

Drug NameBNT-153
Drug Alias NameBNT-153
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionImmunostimulantsInterleukin-2 stimulants
TargetsInterleukin-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiontech Se
China Registration ClassN/A

Develop Information

Active CompaniesBiontech Se
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A